Home / 2019 / June / 20

Daily Archives: June 20, 2019

Constellation Brands CEO Bill Newlands Signs CEO Action for Diversity & Inclusion Pledge

VICTOR, N.Y., June 20, 2019 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that that Bill Newlands, president and chief executive officer, is joining CEO Action for Diversity & Inclusion™ – the largest CEO-driven business commitment to advance diversity and inclusion within the workplace.

The CEO Action for Diversity & Inclusion recognizes that change often happens when there’s support at the executive level. More than 600 CEOs of the world’s leading companies and business organizations are leveraging their voices to advance diversity and inclusion in the workplace by placing individual accountability on all—leaders and employees—to create inclusive environments.

“At Constellation, we work hard to foster an inclusive culture that is characterized by diversity in background and thought, and that reflects our consumers and the communities where we live and work,” said Newlands. “Signing the CEO Action for Diversity & Inclusion pledge is just one more way we can bring this culture to life. Committing myself and this organization through the pledge is the right thing to do – for our communities, workforce, and business.”

Constellation Brands’ diversity and inclusion strategy prioritizes insights, training and education, and employee engagement programs. The company is continuously developing a suite of impactful resources, tools and education courses – from unconscious bias training, cross-cultural leadership, working with generations, inclusive leadership and more – to support employees in building cultural awareness and recognizing and managing the barriers to inclusion. Business Resource Groups offer support and empowerment opportunities for women, early career professionals, LGBTQ, and Hispanic/Latinx employees.

An area of focus for Constellation is continuing to enhance female perspectives within the business and to include more voices, insights, and viewpoints that reflect the company’s consumers. Approximately one-third of Constellation Brands’ leadership positions are held by women today, and in the last five years, the company has doubled the number of women in senior roles. Additionally, Constellation supports the development of women through the Women’s Leadership Development Program and innovating products that resonate with female consumers.

About Constellation Brands
Constellation Brands (NYSE: STZ and STZ.B), a Fortune 500® company, is a leading international producer and marketer of beer, wine and spirits with operations in the U.S., Mexico, New Zealand, Italy, and Canada. Constellation is the No. 3 beer company in the U.S. with high-end, iconic imported beer brands such as the Corona and Modelo brand families, and Pacifico. Its high-quality wine and spirits brands include the Robert Mondavi and The Prisoner Wine Company brand families, Kim Crawford, Ruffino, Meiomi, and SVEDKA Vodka. The company’s portfolio also includes a collection of highly-rated wine brands such as SIMI and Mount Veeder Winery, spirits brands High West Whiskey and Casa Noble Tequila, as well as new wine innovations such as Cooper & Thief and Spoken Barrel.

Based in Victor, N.Y., the company believes that industry leadership involves a commitment to brand building, our trade partners, the environment, our investors, and to consumers around the world who choose our products when celebrating big moments or enjoying quiet ones. Since its founding in 1945, Constellation’s ability to see, meet and stay ahead of shifting consumer preferences and trends across total beverage alcohol has fueled our success and made us the No. 1 growth contributor in beverage alcohol in the U.S.

To learn more, follow us on Twitter @cbrands and visit www.cbrands.com.

Mike McGrew   773-251-4934 michael.mcgrew@cbrands.com Patty Yahn-Urlaub  585-678-7483  patty.yahn-urlaub@cbrands.com
Amy Martin   585-678-7141 amy.martin@cbrands.com Bob Czudak  585-678-7170  bob.czudak@cbrands.com
Tom Conaway  585-678-7503  thomas.conaway@cbrands.com

A downloadable PDF copy of this news release enhanced with multimedia links can be found here: http://ml.globenewswire.com/Resource/Download/4d3c67ec-bb70-4c51-889b-719b0f13a517

Philips extends advanced automation capabilities on its EPIQ CVx cardiology ultrasound platform, making accurate exams faster and easier to conduct

June 20, 2019

  • With new release, clinicians can reduce the number of touches of the system by 21% per exam, equivalent to more than 400 exams each year
  • Platform provides advanced automation for right ventricle volumes and ejection fraction measurements in as little as 15 seconds, speeding exam times

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new advanced automation capabilities on its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems. With Release 5.0, both the EPIQ CVx and EPIQ CVxi now include automated applications for 2D assessment of the heart, as well as robust 3D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct [1]. Together, the new applications provide clinicians with the means to confidently evaluate the heart’s function, increasing diagnostic confidence for patients with pulmonary hypertension, congenital heart disease, coronary disease and heart failure.

“The complexity of cardiac exams can be a barrier to accessing high quality care. Philips is addressing this by leveraging Artificial Intelligence to make echo exams easier, faster and more reproducible,” said David Handler, General Manager of Cardiac Ultrasound at Philips. “By incorporating advanced automation, there is less variability between scans, leading to accurate treatment decisions which benefits patients. The new release of EPIQ CVx is a major step forward, reducing the number of touches of the system by 21% in each exam, which is equivalent to more than 400 exams each year [2].”

The AutoStrain LV application uses advanced Automatic View Recognition technology to identify the different views of the heart, providing exceptional visualization and analysis of left ventricular function – extremely important diagnostic information for patients at risk of developing cardiovascular disease. Also available are AutoStrain LA and AutoStrain RV, applications which automate the measurement of left atrial and right ventricular longitudinal strain respectively. By creating reliable and reproducible strain measurements for the left ventricle, left atrium and right ventricle, the AutoStrain LV, LA and RV applications support clinicians treating patients with atrial fibrillation, arrhythmia and other complex heart conditions.

The 3D Auto RV application segments, identifies the borders of and aligns the views of the right ventricle, enabling clinicians to carry out the quantification and check the measurements in as little as 15 seconds [3]. These new applications expand on the advanced automation applications already available on the EPIQ CVx platform, including Dynamic HeartModel, which provides a clear vision of the heart’s chambers and how well they are pumping blood – specifically on the left side, where heart failure often begins. A recent study of Dynamic HeartModel published in the European Heart Journal – Cardiovascular Imaging concluded that ‘the automated algorithm can quickly measure dynamic left ventricle and left atrial volumes and accurately analyze ejection/filling parameters’ [4].

The new release also adds diagnostic capabilities to the EPIC CVxi. Tailored for use in the interventional lab, the system can now also be used in the echo lab.

Advanced automation makes echo more accessible to a growing patient base
Beyond monitoring overall heart function, new medical fields such as cardio-oncology are using echocardiography to better assess heart health during chemotherapy, which can damage the heart if the dosage is not closely monitored. Cardio-oncology has increased the global demand for echocardiography as clinicians need to perform a deep analysis on cardiac images throughout the patient’s treatment, ensuring measurements are consistent from one exam to the next so that the results can be reliably compared.

Philips will unveil EPIQ CVx Release 5.0 alongside its full suite of solutions for diagnosis and interventional guidance during the annual meeting of the American Society of Echo (ASE), taking place June 21-25 in Portland, Oregon. Follow the #ASE2019 conversation on @PhilipsLiveFrom throughout the event and visit Philips on booth #300. More information about the Release 5.0 is available here.

[1] The Philips CVx and CVxi 5.0 Diagnostic ultrasound systems are available for sale globally. The AutoStrain LV, LA, RV applications and the Dynamic Heart Model application are CE marked and FDA cleared and available for sale in Europe and in the USA. The AI enabled 3D AutoRV application, designed using a Machine Learning-based algorithm, is CE marked and FDA 510(k) pending, and is therefore available for sale in Europe but is not available for sale in the USA.
[2] Based on eight scans per day over 48 weeks.
[3] Based on internal test results.
[4] European Heart Journal – Cardiovascular Imaging, “Machine learning based automated dynamic quantification of left heart chambers volumes,” October 9, 2018.

For further information, please contact:

Mark Groves
Philips Group Press Office
Tel: +31 631 639 916
Email: mark.groves@philips.com
Twitter: @mark_groves

Sarah Haeger
Philips Ultrasound
Tel: +1 206-920-8726
Email: sarah.haeger@philips.com
Twitter: @sarahhaeger

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.


TeraRecon Receives First-of-Kind FDA Determination

DURHAM, N.C., June 20, 2019 (GLOBE NEWSWIRE) — Advanced visualization and artificial intelligence (AI) technology provider, TeraRecon, today announced it has successfully completed an FDA regulatory review of its Northstar™ AI Results Explorer, for which the technology and the determination are both firsts-of-kind in the medical imaging industry.  Northstar is designed to work alongside the company’s EnvoyAI™ interoperability platform which includes FDA-cleared 3rd party content listed on its EnvoyAI Exchange marketplace. The Northstar determination letter reinforces the company’s commitment to regulatory and quality standards along with transparency in the field of medical imaging artificial intelligence.

The Northstar AI Results Explorer provides an engaging physician user experience which can be integrated into the clinical systems already used throughout the health enterprise. Now with full commercial availability, Northstar can provide physicians an important way to accept, reject, and interact with AI-derived findings. Through the EnvoyAI marketplace, health systems can enter into a single contractual agreement and confidently run algorithms interchangeably, with a single two-hour software installation.

EnvoyAI is the world’s first AI marketplace and the only AI interoperability platform. EnvoyAI customers currently have access to over 80 algorithms with 20 holding regulatory clearances in various global territories.

“As the medical AI market continues to mature, global regulatory bodies are growing ever more vigilant and confident in assessing these emerging technologies,” noted Patty O’Brien, Vice President Regulatory Affairs at TeraRecon.   “It is gratifying to work in today’s collaborative regulatory environment and to do our part as an industry partner in the process.”

With deep domain expertise involving class II medical imaging software devices, TeraRecon maintains stringent processes, documentation and quality systems across its design, development and business operations.  The FDA has determined that the Northstar AI Results Explorer is exempt from Class II premarket notification requirements and therefore is considered a Class I medical device alongside their existing Class I EnvoyAI platform.

“TeraRecon technologies are always designed keeping their future value in mind,” said Jeff Sorenson, TeraRecon CEO.  “We know that our artificial intelligence solutions are only the tip of the transformation iceberg and that workflows will only grow more sophisticated over time. Product requirements will continue to evolve and become deeply clinical and highly specialized, requiring much more than just a marketplace to deliver them. We expect any advanced AI workflow solutions will require the same level of diligence and sophistication as advanced visualization solutions do today, if not more,” said TeraRecon CEO, Jeff Sorenson.

TeraRecon technologies including the EnvoyAI platform, TeraRecon Northstar AI Results Explorer, and its flagship iNtuition™ advanced visualization solution, will be on display at the Society for Imaging Informatics in Medicine (Book a demo at SIIM) in Aurora, Colorado from June 26th – June 28th, 2019. Online demonstrations are available by contacting TeraRecon at info@terarecon.com.

About TeraRecon (www.terarecon.comTeraRecon is a leader in medical advanced visualization and artificial intelligence solutions. Their flagship product, iNtuition, consistently leads the advanced visualization category of the industry’s leading independent technology analyst. The company continues to innovate ahead of customer demand and has most recently developed new sophisticated healthcare-focused artificial intelligence platform solutions unlike any in the world today. EnvoyAI was the recipient of the prestigious Aunt Minnie 2018 Best New Radiology Vendor award. TeraRecon’s Northstar AI Results Explorer is the first and only enterprise-wide solution capable of delivering AI imaging insights directly and interactively into the systems clinicians use every day. As a company with a 20-year history of innovation, TeraRecon’s mission is to continuously redefine medical advanced visualization and leverage artificial intelligence to improve patient care.

Press Inquiries US: 1-650-372-1100 | info@terarecon.com

TeraRecon, iNtuition, EnvoyAI, and Northstar are trademarks of TeraRecon, Inc.

Malaysia looking two steps ahead to capitalise on US-China trade war – Lim

KUALA LUMPUR, Malaysia is capitalising on the permanent reorientation of the global supply chain following the US-China trade war by upping competitiveness to attract new high-quality investments, especially those concerning Industry 4.0, said Finance Minister Lim Guan Eng.

This focus will enable the country to take advantage of the next global growth upswing when the time comes, he said.

“In other words, we are readying ourselves two steps ahead; we are preparing for the worst of the trade war, and what comes next five to 10 years down the road,” he said in his speech during the British Malaysian Chamber of Commerce’s second Business Excellence Awards tonight.

He said at present, Malaysia is already among the top countries benefiting from business relocation as well as trade and investment diversion arising from the US-China trade war.

Lim said this can be seen from the first-quarter 2019 approved foreign direct investment (FDI) that jumped 73.4 per cent to RM29.3 billion from RM16.9 billion a year earlier.

In addition, approved manufacturing FDI surged 127 per cent to RM20.2 billion from RM8.9 billion previously.

Lim said the US and China were the largest sources of approved FDI during the quarter.

“Out of the RM20.2 billion of approved FDI in manufacturing, RM11.5 billion originated from the US and RM4.4 billion from China, he said.

Lim said Malaysia has already been acknowledged as the 22nd most competitive country out of 63 economies in the world in 2019 by the International Institute for Management Development while the World Bank ranked Malaysia as the 15th easiest place to do business out of 190 countries.

“We are a competitive safe haven for global companies,” he said.

On Malaysia-UK trade relations, he said despite the deep ties between the two countries, he believes more can be done via trade and investment channels to raise the prosperity of their peoples.

We have a golden opportunity to do so at a time of fundamental global supply chain reorientation in the Pacific or in the Atlantic. Now is the perfect time for UK companies to invest in Malaysia and be ready, like Malaysia, for the next stage, Lim said.

The UK is among Malaysia’s top 20 most important trade partners, with Malaysia exporting RM8.6 billion of goods to the country and importing RM7 billion in 2018 (excluding service trade).

This brought the Malaysia-UK total trade to RM15.6 billion, with a RM1.6 billion surplus in Malaysia’s favour.

As for exports of services, he said Malaysia recorded a service trade deficit following higher imports of RM10.8 billion compared to an exports value of RM7.8 billion.

He expressed hope that the deficit can be reduced in the future.

In addition, the UK is the eighth largest investor in Malaysia with RM22.3 billion worth of FDI stock by end-2018.

Source: BERNAMA (News Agency)

Malaysia set to capitalise on opportunities from US-China trade war – Azmin

KUALA LUMPUR, The US-China trade war has opened a unique opportunity for Southeast Asian countries and Malaysia stands ready to exploit the economic opportunities that may ensue, said Economic Affairs Minister Datuk Seri Mohamed Azmin Ali.

He said international competition is always fluid; therefore, businesses will naturally look for alternative investment destinations to overcome the trade barriers imposed.

We are ready to accept new investments that wish to take advantage of our modern infrastructure, connectivity to the region, political stability and pool of skilled and knowledge workers, he said in his special address at the Asia Business Leadership Excellence and Lifetime Achievement Awards and gala dinner.

The event was held in conjunction with the Asia Economic And Entrepreneurship Summit themed The Future Of Asia In A New Era Of Disruption And Trade Wars held today.

Azmin noted that smaller economies would be expected to suffer the consequences when two of the world’s largest economies clash and engage in a relentless trade war.

The normal knee-jerk reaction, he said, would be to predict negative trade flows as well as adverse effects on economic growth, with financial markets usually reacting by reducing their exposure in the affected economies.

Azmin reiterated Malaysia’s commitment in continuing its business-friendly policies even as the government introduces policy changes to ensure greater transparency and accountability.

He said Malaysia is actively pursuing a regional and global policy of business and trade interconnectivity.

He noted that the trade balance in the sub-regional cooperation within ASEAN known as the East Asian Gowth Area (BIMP-EAGA) grew by 39.2 per cent with a value of US$54.7 billion in the period of 2016 2017.

Its export value grew to US$79 billion within the same period. We are confident this will further accelerate economic development for the region, he said.

He added that the forthcoming ASEAN Summit will further cement regional cooperation to boost economic and business activities for member states.

Source: BERNAMA (News Agency)

Boustead Naval Shipyard secures contract worth RM95.99 million

KUALA LUMPUR, Boustead Holdings Bhd’s subsidiary, Boustead Naval Shipyard Sdn Bhd (BNS) has secured a RM95.99 million contract for refit works on KD Terengganu from the Ministry of Defence Malaysia.

In a filing with Bursa Malaysia today, Boustead said a formal contract between the Malaysian government and BNS will be signed at a later date.

The contract is expected to contribute positively to current and future earnings of the group.

Source: BERNAMA (News Agency)

CoolBlog targets to open more branches in rural areas

PETALING JAYA, CoolBlog Dessert Sdn Bhd targets to strengthen its presence in the country particularly in the rural areas including Sabah and Sarawak in the next five years.

Its manager (marketing and business development) Win Z. Zakaria said towards that end, the company aimed to increase the number of branches nationwide in a bid to reinforce its position.

We want to balance the company-owned outlets and those under franchise, because at present, the ratio of company-owned branches and franchise is 30:70. The objective is ensure that the marketing campaign can be implemented in tandem, he said to Bernama after launching the company’s latest drink, Unicool, here today.

He said the company was also active in participating in trade missions to foreign countries organised by the Malaysia External Trade Development Corporation (MATRADE) and Malaysia Franchise Association (MFA).

We also take part in trade missions organised by MATRADE and MFA, besides getting guidance and information to expand the business to foreign markets especially in ASEAN, he said.

The new drink flavour produced by CoolBlog was inspired by the beautiful colours of the rainbow, fantasy and fairy tales, made available in three flavours — Unicool Magical, Unicool Dazzle and Unicool Twinkle, and sold at RM7.50 for the 700 ml cup.

Win said as a pioneer in the beverage category based on ice blended in Malaysia, CoolBlog was always striving to serve something different and this enabled it to continue controlling the consumer and market segments.

Affiliation, collaboration and innovation are the key factors in formulating any product development planning, he added.

Source: BERNAMA (News Agency)